SUNY Poly Assistant Professor Dr. Amit Sangwan and colleagues recently published research titled "Feasibility Testing of the ...

Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device ...

Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device ...

The authorised ANDA is a therapeutic equivalent of the reference-listed drug (RLD), Corlanor tablets, in the same 5 mg and ...

Catheter Precision, Inc. (NYSE American:VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for ...

Reached alignment with FDA on key elements of registrational development plan for LX2006, including accelerated approval ...

In MI patients with preserved heart function, beta-blockers are linked to higher depressive symptoms, indicating a need for ...

Some patients with advanced heart failure can benefit from the support of a continuous-flow left ventricular assist device (CF-LVAD) to sustain heart function. However, despite improvements managing ...

CARMAT's Aeson® artificial heart is gradually becoming a reference solution for bridge to transplant in Europe.

It’s a life-threatening condition that can occur at anytime, anywhere. The most common arrhythmia is ventricular fibrillation ...

Advances are helping people born with heart defects to make it into adulthood and retirement age. Medical care hasn't kept up ...

Revenue: Total revenue was $2.1 million for the quarter ended September 30, 2024, comprised of $0.6 million in net product ...